# Why Orthoptics Is Heavily Deployed in the UK and Australia but Lightly Deployed in the United States

## Headline comparison

The short version is this: **the UK and Australia built orthoptics into their delivery systems as a named workforce with formal education pathways and service roles, while the U.S. left orthoptics as a tiny certification-based subspecialty nested inside ophthalmology practices.** The result is a profound per-capita workforce difference. Using the best recent country-specific counts I could verify, the U.S. has **fewer than 0.12 orthoptists per 100,000 people**, the UK has about **2.61 per 100,000**, and Australia has about **4.1 per 100,000**. Even after allowing for imperfect cross-country comparability in how “orthoptist” is counted, the U.S. is an order of magnitude smaller. citeturn10search3turn28search17turn29search4turn1search15turn30search2turn31search15turn32search15turn33search15

**Clean per-100k comparison**

| Country | Practicing orthoptists | Orthoptists per 100,000 population | Orthoptists per 100,000 children | Year(s) used | Counting definition |
|---|---:|---:|---:|---|---|
| **United States** | **Under 400** | **<0.12** | **<0.55** using U.S. under-18 population | 2026 workforce statement; 2024 population/children | AACO/AOC describes the U.S. profession as having “numbers ranging under 400 in the entire country”; this is a **certified-practitioner estimate**, not a licensure register. citeturn10search3turn28search17turn29search4 |
| **United Kingdom** | **1,805** | **2.61** | **14.3** using UK under-16 population share | Jan 2025 register; mid-2024 population | HCPC registrants in the orthoptist profession on the UK register; this is a **statutory registration count**, not the subset actively working in the NHS full time. citeturn1search15turn30search2turn31search15 |
| **Australia** | **1,055** | **4.1** | **22.0** using 2021 Australia age 0–14 population | 2021 workforce/population | Peer-reviewed summary citing AIHW workforce data; this is a **workforce estimate**, not a statutory national licensure register. Australia is self-regulated through the Australian Orthoptic Board rather than AHPRA licensure. citeturn11search15turn32search15turn33search15turn23search19turn23search11 |

A direct apples-to-apples child denominator is **not** available across all three countries from one harmonized source. In this report, the U.S. child denominator is **under age 18**, the UK child denominator is **under age 16**, and Australia’s is **age 0–14**, because those were the defensible recent denominators I could verify from official or peer-reviewed sources. That inconsistency matters, but it does **not** erase the much larger headline point: the U.S. orthoptic workforce is structurally tiny compared with the UK and Australia. citeturn29search4turn31search15turn33search15

## Stat cards

| Value | Metric / what it measures | Scope & population | Period | Source | Confidence | One-line “so what” |
|---|---|---|---|---|---|---|
| **Under 400** | U.S. practicing certified orthoptists | United States; profession-wide estimate | AACO/AOC page live in 2026 | AACO/AOC profession page citeturn10search3 | **[Low-confidence]** | The U.S. profession is so small that even its main professional body publishes only a broad “under 400” estimate, not a formal live registry count. |
| **340,110,988** | U.S. resident population | United States | July 1, 2024 | U.S. Census QuickFacts citeturn28search17 | **[Measured]** | This is the denominator for recent U.S. per-capita calculations. |
| **73.1 million** | U.S. population under age 18 | United States | 2024 estimate | U.S. Census Bureau release on older adults vs children citeturn29search4 | **[Measured]** | Even on a child-specific denominator, U.S. orthoptist availability remains extremely low. |
| **<0.12 per 100,000** | U.S. orthoptists per 100,000 total population | United States | 2026 count estimate / 2024 denominator | Derived from AACO/AOC + Census sources above citeturn10search3turn28search17 | **[Estimate]** | The U.S. orthoptist workforce is not merely small; it is effectively invisible at national scale. |
| **<0.55 per 100,000 children** | U.S. orthoptists per 100,000 children | United States; under age 18 denominator | 2026 count estimate / 2024 denominator | Derived from AACO/AOC + Census sources above citeturn10search3turn29search4 | **[Estimate]** | Even where orthoptists are most clinically relevant—children—the U.S. has very thin coverage. |
| **1,805** | Registered orthoptists | United Kingdom | January 2025 | HCPC registrant snapshot and orthoptist profile citeturn1search15 | **[Measured]** | The UK has a statutory orthoptist register, which makes the workforce visible and governable. |
| **69,281,400** | UK population | United Kingdom | Mid-2024 | ONS annual mid-year population estimates citeturn30search2 | **[Measured]** | This is the recent national denominator for UK per-capita workforce. |
| **18.2%** | Share of UK population who are children under 16 | United Kingdom | Mid-2024 | ONS 2024-based national population projections citeturn31search15 | **[Estimate]** | This allows a recent child-population denominator, though it is under-16 rather than under-18. |
| **2.61 per 100,000** | UK orthoptists per 100,000 total population | United Kingdom | Jan 2025 register / mid-2024 denominator | Derived from HCPC + ONS sources above citeturn1search15turn30search2 | **[Estimate]** | The UK has roughly **22 times** the U.S. per-capita orthoptic workforce if the U.S. is taken at its upper-bound estimate. |
| **14.3 per 100,000 children** | UK orthoptists per 100,000 children | United Kingdom; under age 16 denominator | Jan 2025 register / mid-2024 denominator | Derived from HCPC + ONS sources above citeturn1search15turn31search15 | **[Estimate]** | UK service design makes pediatric orthoptic capacity far denser than in the U.S. |
| **1,055** | Orthoptists in workforce | Australia | 2021 | Peer-reviewed review summarizing AIHW workforce data citeturn11search15 | **[Estimate]** | Australia’s orthoptic workforce appears not just larger than the U.S.; on this count it is larger than the UK per capita as well. |
| **25.7 million** | Australia population | Australia | 2021 | ABS historical population release citeturn32search15 | **[Measured]** | This matches the same general period as the orthoptist workforce estimate. |
| **4.8 million** | Australia children aged 0–14 | Australia | 2021 | ABS Life Course Dataset scoping paper citeturn33search15 | **[Measured]** | This provides a defensible child denominator for 2021 Australia. |
| **4.1 per 100,000** | Australia orthoptists per 100,000 total population | Australia | 2021 | Derived from AIHW-linked workforce estimate + ABS denominator citeturn11search15turn32search15 | **[Estimate]** | Australia has built orthoptics into mainstream eye care to a degree the U.S. has not. |
| **22.0 per 100,000 children** | Australia orthoptists per 100,000 children | Australia; age 0–14 denominator | 2021 | Derived from workforce estimate + ABS child denominator citeturn11search15turn33search15 | **[Estimate]** | Pediatric and developmental eye-care capacity is likely much more orthoptist-rich in Australia than in the U.S. |
| **154** | Practicing orthoptists identified | Canada | 2026 | Canadian Journal of Ophthalmology article summary citeturn26search3 | **[Measured]** | Canada also appears to have a small and uneven workforce, but still one that is being explicitly measured. |
| **16,171** | Certified orthoptists | Japan | As of December 31, 2019 | Japanese Association of Certified Orthoptists citeturn24search3 | **[Measured]** | Japan shows what a heavily institutionalized orthoptic profession can look like at national scale. |
| **17** | U.S. orthoptic fellowship programs “currently accepting students” | United States | 2026 | AACO/AOC training pages citeturn14search0turn13view0 | **[Measured]** | The U.S. has more training sites than many people assume, but the pipeline still yields a tiny national workforce. |
| **5** | UK approved pre-registration orthoptist programmes | United Kingdom | September 1, 2025 | HCPC education annual report 2024–25 citeturn21view0 | **[Measured]** | The UK’s pipeline is small in absolute number of schools, but large relative to population and tightly linked to a regulated profession. |
| **276** | UK orthoptist learner-number capacity | United Kingdom | September 1, 2025 | HCPC education annual report 2024–25 citeturn21view0 | **[Estimate]** | This is not actual admissions or graduates, but it is a rare official proxy showing meaningful training capacity. |
| **2** | Australian orthoptic education locations | Australia | Current page live in 2026 | Orthoptics Australia and Australian Orthoptic Board citeturn22search2turn22search10 | **[Measured]** | Australia trains orthoptists at only two sites, yet still sustains a much larger workforce than the U.S. |
| **0%** | Growth in UK orthoptist programme numbers | United Kingdom | 2024–25 academic year | HCPC education annual report 2024–25 citeturn21view0 | **[Measured]** | UK university-route program count was flat recently, so service capacity is being maintained more than rapidly expanded. |
| **1** | New orthoptics apprenticeship route launching | United Kingdom | September 2026 | BIOS careers page citeturn17search22 | **[Measured]** | The UK is actively creating additional “earn and learn” pipeline capacity rather than relying only on traditional degree routes. |
| **90% to 100%** | Graduate employment within 6 months | UK orthoptic graduates | BIOS career profile, current guidance PDF | BIOS career profile PDF citeturn17search9 | **[Estimate]** | Heavy orthoptic deployment is reflected in labor-market absorption: UK graduates appear to move into practice quickly. |
| **2 years** | Length of U.S. orthoptic post-graduate training | United States | Current guidance live in 2026 | AOC/AACO training pages citeturn12search2turn12search6 | **[Measured]** | U.S. orthoptics is specialized and lengthy to train, which raises the bar for entry into a profession that lacks strong reimbursement visibility. |
| **3–4 years** | Length of UK orthoptic degree training | United Kingdom | Current guidance live in 2026 | BIOS careers pages citeturn15search3turn17search16 | **[Measured]** | In the UK, orthoptics is an identifiable entry-level degree profession, not just a post-grad niche. |
| **$33.98** | Example Medicaid fee for CPT 92060 | Montana Medicaid optometric services | January 1, 2025 fee schedule | Montana Medicaid fee schedule citeturn34search18 | **[Measured]** | Orthoptic/sensorimotor work can be reimbursed in U.S. payer schedules, but this does not make orthoptists independent billers. |
| **$37.10** | Example Medicaid fee for CPT 92065 | Montana Medicaid optometric services | January 1, 2025 fee schedule | Montana Medicaid fee schedule citeturn34search18 | **[Measured]** | The code is still active in state Medicaid, but the payment level is modest. |
| **41,300** | Employment in BLS category that contains orthoptists | U.S. “Healthcare diagnosing or treating practitioners, all other” | 2024 | BLS OOH / O*NET crosswalk citeturn42search0turn42search3 | **[Measured]** | Federal labor statistics do not count orthoptists separately; they disappear into an “all other” bucket. |
| **78,800** | Ophthalmic medical technicians employed | United States | 2024 | BLS OOH | citeturn42search0 | **[Measured]** | In the U.S., orthoptic-type work is often absorbed into larger adjacent ophthalmic roles rather than a distinct orthoptist workforce. |
| **45%** | Stroke survivors found to have visual impairment in cohort | UK stroke services | Study published 2010 | PubMed summary of Rowe et al. citeturn41search1 | **[Measured]** | This shows why a dedicated visual-assessment workforce matters in neuro/stroke pathways. |
| **90.24% sensitivity; 85.29% specificity** | Performance of VISA stroke vision screening tool | 89 stroke survivors completing both screening and specialist assessment across 3 UK hospitals | 2018 study | BMJ Open / PubMed citeturn41search3 | **[Measured]** | Orthoptic know-how can be translated into scalable pathway tools that improve detection and referral quality. |
| **116 screened; 89 full completions** | VISA pilot study sample size | UK stroke services | 2018 | BMJ Open / PubMed citeturn41search3 | **[Measured]** | The evidence base is modest in size but operationally relevant. |

## What the numbers mean together

The workforce comparison is not subtle. Even using a generous upper-bound estimate for the U.S. workforce, the United States sits below **0.12 orthoptists per 100,000 population**, versus **2.61** in the UK and **4.1** in Australia. On child-focused denominators, the gap is even starker: **<0.55 per 100,000 U.S. children**, versus **14.3** in the UK and **22.0** in Australia, although those child definitions are not perfectly harmonized. The central finding is robust anyway: **orthoptics is institutionally present in the UK and Australia, but only residually present in the U.S.** citeturn10search3turn28search17turn29search4turn1search15turn30search2turn31search15turn11search15turn32search15turn33search15

The pipeline data point in the same direction. The U.S. has **17** accredited programs currently accepting students, which sounds substantial until it is normalized to population and compared with the profession’s tiny workforce. The UK has only **5** pre-registration programmes, but also a formal statutory register, a documented learner capacity of **276**, and a new apprenticeship route launching in **September 2026**. Australia has only **2** education sites, yet still sustains a much larger workforce than the U.S. because the role is more deeply embedded in service delivery. In other words, **training site counts matter less than whether the health system has an obvious destination for graduates.** citeturn14search0turn13view0turn21view0turn17search22turn22search2turn22search10

That destination is much clearer in the UK, where orthoptists are a regulated profession on the HCPC register and are heavily linked to NHS hospital eye services. BIOS’ own career profile says **90% to 100% of orthoptic graduates find employment within 6 months**, mostly in the NHS. The U.S. has no corresponding state licensure system, no federal workforce series specific to orthoptists, and no separate Medicare enrollment pathway for orthoptists as independent billing professionals that I could verify. The profession therefore remains clinically real but administratively faint. citeturn1search15turn17search9turn39search1turn42search0turn42search3

## Why the systems diverge

The main structural difference is **how the role is institutionalized**.

In the **UK**, orthoptists sit inside a fully legible professional architecture: HCPC registration, approved entry-to-practice programmes, protected title, NHS salaried posts, and profession-specific workforce planning. HCPC also approves post-registration training for orthoptists to use medicines exemptions, and the register can carry that annotation. This is what “deployed heavily” looks like in practice: orthoptists are not just helpers in an ophthalmologist’s office; they are a named workforce that the system can train, regulate, count, and place into service lines. citeturn1search15turn19search15turn21view0

In **Australia**, the role is also much more visible than in the U.S., but through a different structure. Orthoptics is **industry self-regulated**, with optional registration through the Australian Orthoptic Board rather than statutory AHPRA registration. Even so, Orthoptics Australia and the AOB provide a national professional and registration framework, and official/public-facing sources note that many employers and most public hospitals expect AOB registration. Combined with only **two** university training locations and a workforce estimate of **1,055** orthoptists in 2021, that implies a role that is clearly recognized by employers and systems even without full statutory licensure. citeturn23search11turn23search19turn23search5turn22search2turn22search10turn11search15

The **U.S.** is the opposite case. Orthoptists are certified by the American Orthoptic Council, but the profession itself says there are “numbers ranging under 400” in the country and is described as a “small specialty profession.” There is no state licensure structure comparable to HCPC registration. The CMS physician/non-physician practitioner enrollment form points to “physicians” and “eligible professionals” defined in the Social Security Act, but orthoptists are not named there as a standalone Medicare practitioner type. That means U.S. orthoptists usually function inside ophthalmology practices rather than as independently recognized billing providers. citeturn10search3turn39search1turn40search2

That has reimbursement consequences. In U.S. fee-for-service practice, orthoptic work often appears under physician billing rather than orthoptist billing. The relevant work is real, and the billing codes are real: AAO explains CPT **92060** as the sensorimotor exam used in strabismus workups, and state Medicaid fee schedules still list CPT **92065** for orthoptic/pleoptic training. For example, Montana Medicaid’s January 2025 fee schedule lists **$33.98** for 92060 and **$37.10** for 92065, with a lower facility amount shown for 92065. But those payments are attached to billable ophthalmic services, not to an orthoptist as an independently recognized national provider type. In the U.S., orthoptists therefore resemble a **physician-extender workforce without a strong billing identity of its own**. citeturn34search2turn34search18turn11search0turn39search1

This is also why U.S. orthoptic labor gets absorbed into adjacent roles. The federal workforce system does not give orthoptists a clean employment series; BLS places them under **“Healthcare Diagnosing or Treating Practitioners, All Other”** and O*NET crosswalks orthoptists into that same SOC bucket. Meanwhile, BLS counts **78,800 ophthalmic medical technicians** as a standalone adjoining occupation. So the U.S. system has a ready-made place to expand technician labor, but not a comparable institutional slot for orthoptists as a distinct profession. citeturn42search0turn42search3

## What the United States gives up

The main loss is not that Americans receive *no* orthoptic care. They do receive it. The loss is that the U.S. gets it in a **more fragile, less visible, and less scalable form**.

The clearest operational evidence comes from service-redesign studies. A 2015 PubMed-indexed paper on U.S. pediatric eye care concluded that using an orthoptist as a physician extender improves practice efficiency in a cost-effective manner. In the UK evidence base, orthoptist-led models have repeatedly been shown to open service capacity beyond the classic pediatric strabismus lane: a 2023 study concluded that an orthoptist-led clinic for screening optic pathway gliomas in neurofibromatosis type 1 was a more cost-efficient model of care, and a 2023 quality-assurance audit reported that an orthoptist-led virtual neuro-ophthalmology clinic was a viable way to deliver safe care in a high-demand subspecialty. These are exactly the kinds of roles that a tiny, weakly institutionalized U.S. workforce cannot scale nationally. citeturn11search0turn41search0turn41search2

The neuro/stroke literature makes the opportunity cost even clearer. In one UK study, **45%** of stroke survivors had visual impairment, and the authors found that only **orthoptic-led screening** provided quantitative assessment of acuity, ocular motility, and fields. A later validation study of the VISA screening tool in **116** stroke survivors found **90.24% sensitivity** and **85.29% specificity** when compared with specialist assessment. Another review argued directly that orthoptists embedded in stroke teams are beneficial for high-quality stroke and vision care. In practical terms, this means the U.S. gives up a workforce that can either perform specialist neuro-visual assessment or build scalable screening-and-referral pathways when ophthalmologist time is scarce. citeturn41search1turn41search3turn41search4

What the U.S. likely gives up, then, is:

First, **capacity**. Orthoptists can do strabismus measurements, amblyopia follow-up, diplopia workups, convergence/accommodative management, neuro-ophthalmic visual-function assessment, and pre/post-operative sensorimotor evaluation. If those functions are not institutionally assigned to orthoptists, they get redistributed to ophthalmologists, technicians, or fragmented care pathways instead. citeturn9search2turn23search16turn17search16

Second, **efficiency**. Orthoptist-led or orthoptist-extended models free ophthalmologists for the parts of care that only they can do. The U.S. literature explicitly frames orthoptists as physician extenders in pediatric ophthalmology; the UK literature shows the same logic applied more broadly. citeturn11search0turn41search0turn41search2

Third, **access pathway reliability**. A regulated, named workforce can be put into school screening, stroke units, neurofibromatosis surveillance, virtual neuro-ophthalmology, learning-disability access programs, and hospital eye-service triage. The UK evidence brief shows that these uses already exist. The U.S. can replicate pieces of this, but not with the same workforce visibility or planning coherence. citeturn18view0

Fourth, **data visibility**. Because the U.S. does not license orthoptists by state and BLS does not count them separately, it is hard even to prove the size of the shortage with precision. That invisibility becomes self-reinforcing: if a profession is not measured cleanly, it is harder to plan, reimburse, advocate for, or expand. citeturn10search3turn42search0turn42search3

A direct cross-country comparison linking heavier orthoptic deployment to better national amblyopia outcomes or shorter wait lists was **not** well supported by the evidence I could verify here, so I would not overclaim that point. The stronger, better-supported claim is narrower: **systems that formally deploy orthoptists can offload specialist work, create dedicated screening and follow-up pathways, and make that labor visible enough to train and regulate at scale.** The U.S. foregoes those advantages when orthoptic work remains bundled, hidden, or absorbed into other job categories. citeturn11search0turn41search0turn41search2turn42search0

## Data gaps

The data scarcity is not just a research inconvenience. It is part of the finding.

- **The U.S. lacks a statutory orthoptist registry.** That leaves AACO/AOC using broad profession-level estimates rather than a continuously published licensure denominator. citeturn10search3
- **Federal labor statistics do not isolate orthoptists.** BLS folds them into “Healthcare Diagnosing or Treating Practitioners, All Other,” which blocks clean national employment, wage, and state-distribution series. citeturn42search0turn42search3
- **Actual annual graduate counts are weakly published.** I could verify program counts in the U.S., UK, Australia, and Canada, and UK learner-capacity data, but not a consistent recent official series of annual graduates across countries. citeturn14search0turn21view0turn22search2turn27search0
- **Cross-country scope-of-practice and counting definitions differ.** UK figures come from a statutory register; Australian figures are workforce estimates in a self-regulated profession; U.S. figures are certification-based estimates. That means cross-country rank order is clear, but exact multiples should be read with caution. citeturn1search15turn11search15turn10search3turn23search19
- **I did not verify a recent official national Medicare payment amount for 92060/92065 in this session.** I could verify the codes’ continued use and an official 2025 state Medicaid fee-schedule example, but not a clean current CMS national payment line item. citeturn34search6turn34search18
- **The strongest “cost of under-deployment” evidence is pathway-level, not country-level.** The literature is good for service redesign, screening performance, and specialty-clinic substitution, but much thinner for direct national comparisons of wait times, screening coverage, or amblyopia outcomes attributable specifically to orthoptist density. citeturn41search0turn41search1turn41search2turn41search3turn41search4